Hence, we identified four candidate biomarkers including angiotensinogen, SAA4, RBP4, and VDBP, which could significantly distinguish RF-positive, RF-negative, ACCP-positive, and ACCP-negative RA patients, and particularly the seronegative (RF- and ACCP-negative) patients. The gene discussed is SAA4; the disease is rheumatoid arthritis.